« Back
Home /
Anti-Human VWF(Caplacizumab)

Anti-Human VWF(Caplacizumab)

Manufacturer	Biointron
Category	Antibodies In Vivo Antibodies
Type	Biosimilars
Specific against	Human
Amount	5mg
Item no.	B22001402-5mg
eClass 6.1	32160702
eClass 9.0	42030590
Available
Alias	ALX-0081,PMP12A2h1-linker AAA-PMP12A2h1,caplacizumab-yhdp;von Willebrand factor) A1 domain
Target	VWF
Clone	Caplacizumab
Isotype	VHH-VHH
Endotoxin	<1EU/mg Determined by LAL gel clotting assay
SDS-PAGE Purity	>95% Determined by SDS-PAGE
Sterility	0.2 μM filtered
Expression System	CHO
Purification	Ni

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

B22001402-5mg-safety-datasheet.pdf